arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Lite Strategy, Inc.

LITS Health Care Biotechnology: Pharmaceutical Preparations
$1.03
Today
as of Jul 22, 16:51 ET
Last 30 days +39.19% Jun 12 → Jul 22
$0.72 $0.80 $0.88 $0.97 $1.05 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$0.82
High
$0.83
Low
$0.70
Volume
$790,333
Avg Vol
$769,535
Mkt Cap
$35M
P/E (TTM)
—
Beta
—
52w High
$9.00
52w Low
$0.70
Div Yield
—
Shares Out
$35M

Recent Press Releases & News last 60 days · 1 item

Jun 18 · 11:45 Investing.com
Exclusive: Lite Strategy leads $1m investment in Litecoin Layer 2 platform LitVM

Overview

52-week range
$0.70
$9.00
4% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-2.8%
0% positive
Latest IV / EM
1295%
EM ±296.1% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.66$0.87$3.40$5.93$8.46 Actual $8.46Actual $-1.66Actual $-1.37Actual $-1.20Actual $-0.40Actual $-0.39Actual $-0.12Actual $-0.82Actual $-0.66 SepDecMarSepDecMar/2025SepDecMar/2026
Revenue vs Net Income Revenue Net income
$-31M$-24M$-17M$-10M$-3M Sep 24Dec 24Mar 25Sep 25Dec 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.66 — — -69.2% -5.6% earnings
Wed Dec 31, 2025Dec 2025 $-0.82 — — — — financials
Tue Sep 30, 2025Sep 2025 $-0.12 — — — — financials
Tue May 13, 2025Mar/2025 $-0.39 — — — 0.0% earnings
Tue Dec 31, 2024Dec 2024 $-0.40 — — — — financials
Mon Sep 30, 2024Sep 2024 $-1.20 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.37 — — — — financials
Sun Dec 31, 2023Dec 2023 $-1.66 — — — — financials
Sat Sep 30, 2023Sep 2023 $8.46 — — — — financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue————$0$0$0—
Cost of revenue————————
Gross profit————————
Operating income$-22M$-30M$-4M—$-3M$-3M$-8M—
Net income$-24M$-31M$-4M—$-3M$-3M$-8M—
EPS (diluted)$-0.66$-0.82$-0.12—$-0.39$-0.40$-1.20—

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$8M$9M$10M$18M$20M$24M$7M$4M
Inventory————————
Total current assets$11M$11M$13M$18M$21M$24M$28M$41M
Total assets$58M$83M$113M$18M$21M$24M$28M$41M
Long-term debt————————
Total liabilities$952,000$1M$1M$1M$1M$2M$3M$8M
Total equity$57M$82M$112M$17M$20M$22M$25M$33M

Implied volatility — last 90 days

1290%2888%4487%6085%7684% Jun 07 — IV 5303% · EM ±734.5%Jun 08 — IV 3561% · EM ±470.3%Jun 09 — IV 3694% · EM ±462.8%Jun 10 — IV 7050% · EM ±832.8%Jun 11 — IV 2997% · EM ±331.2%Jun 12 — IV 4814% · EM ±492.5%Jun 16 — IV 6165% · EM ±364.1%Jun 17 — IV 7685% · EM ±320.9%Jun 19 — IV 3225% · EM ±712.7%Jun 22 — IV 1795% · EM ±374.8%Jun 24 — IV 1859% · EM ±372.3%Jun 25 — IV 2030% · EM ±397.7%Jun 29 — IV 2017% · EM ±357.4%Jun 30 — IV 1983% · EM ±341.5%Jul 01 — IV 1296% · EM ±216.5%Jul 02 — IV 1984% · EM ±320.9%Jul 03 — IV 2054% · EM ±320.9%Jul 07 — IV 2534% · EM ±334.6%Jul 08 — IV 2655% · EM ±332.7%Jul 10 — IV 2554% · EM ±282.2%Jul 13 — IV 4114% · EM ±343.6%Jul 14 — IV 4046% · EM ±292.7%Jul 15 — IV 5392% · EM ±318.5%Jul 16 — IV 7527% · EM ±314.4%Jul 20 — IV 2055% · EM ±485.4%Jul 21 — IV 1290% · EM ±300.0%Jul 22 — IV 1295% · EM ±296.1%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in